News | November 24, 2014

Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening

Researchers: Fully-automated volumetric methods are valid alternatives to measure mammographic breast density and predict breast cancer risk

Dense breast tissue

The accurate measurement of mammographic density offers the potential to improve breast cancer risk prediction and to tailor screening protocols according to risk, according to a study published in Breast Cancer Research (16:439 doi:10.1186/s13058-014-0439-1). The article, “Digital mammographic density and breast cancer risk: a case-control study of six alternative density assessment methods,” demonstrates a strong connection between breast density and breast cancer risk. 

The study details the results of a comprehensive comparison of available mammographic density measurement tools and their ability to predict breast cancer risk. The performance of three area-based approaches (BI-RADS, the semi-automated Cumulus, and the fully-automated ImageJ-based approach) and three fully-automated volumetric methods (VolparaDensity from Volpara Solutions, Quantra from Hologic, and single X-ray absorptiometry (SXA)) were assessed in 3,168 digital mammography images.  This included cancer cases diagnosed at Royal Marsden Hospital in London and normal mammograms from the England and Wales national mammographic screening program.

“Mammographic density is one of the strongest risk factors for breast cancer and is increasingly being used to tailor preventive and screening strategies to a woman’s risk. It is also a major determinant of the sensitivity of mammographic screening and, by extension, the detection of interval cancers. Consequently, in many US states, it is now mandatory to inform screening-attendees of their density,” said Isabel dos-Santos-Silva, M.D., professor of epidemiology at the London School of Hygiene and Tropical Medicine, UK. “The results show that the mammographic density measurements yielded by automated volumetric measurements are as good predictors of breast cancer risk as those generated by well-established, but more labour-intensive methods such as Cumulus.”

All six density assessment methods showed that percent density was inversely associated with age and body mass index (BMI), and certain reproductive factors.  While all of the methods produced positive associations of density with risk, the association was highest for Volpara and Cumulus. Volpara and Cumulus were also the only tools that produced breast density measures for all images in the study, with other methods failing to produce readings for up to 11% of the participants. Women with the highest density had 8.26 times the risk of those with the lowest breast density as measured by Volpara on this dataset (the 95% confidence range was 4.28-15.96). The results also suggest that Volpara is better at identifying women at low risk than the other methods.

“Building on other recently published results looking at the link between breast density and risk, this study led by dos-Santos-Silva continues to reinforce the ability of mammographic density to improve the prediction of breast cancer risk and to help physicians implement tailored screening according to that risk,” said Ralph Highnam, Ph.D., Volpara Solutions CEO and Chief Scientist. “A great deal of research has demonstrated the value of volumetric density, and this study further validates that Volpara’s fully-automated breast density assessment is a valuable tool and has the solid potential for use in helping to predict risk.”

Additional studies are underway to investigate the utility of volumetric methods in screening settings including their contribution to the development of screening approaches tailored to a woman’s risk.

Cleared by the FDA, HealthCanada, the TGA and CE-marked, VolparaDensity is used by radiologists to objectively assess density from both digital mammography and tomosynthesis images to help doctors evaluate who might benefit from additional screening.  Highly correlated to breast MR assessments, VolparaDensity is a reliable tool that automatically generates an objective measurement of volumetric breast density correlated to the ACR (American College of Radiology) breast density categories.  To date, more than 3-million women have had their breast density analyzed, using VolparaDensity.  VolparaDensity is part of a suite of quantitative breast imaging tools built on the Volpara Solutions algorithm that allows for personalized measurements of density, patient dose, breast compression and other factors designed to help maintain accuracy and consistent quality in breast screening.  

For more information: www.volparasolutions.com

Related Content

Doctor-Patient Discussions Neglect Potential Harms of Lung Cancer Screening
News | Lung Cancer | August 15, 2018
August 15, 2018 — Although national guidelines advise doctors to discuss the benefits and harms of...
Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...
Konica Minolta Hosting Lunch and Learn at 23rd Annual Mammography Meeting in Santa Fe
News | Breast Imaging | July 31, 2018
Konica Minolta Healthcare Americas Inc. will sponsor a lunch and learn featuring its Exa Mammo platform during the 23rd...
FDA Approves New Tomosynthesis Quality Control Tests for ACR Digital Mammography QC Manual
News | Mammography | July 30, 2018
The U.S. Food and Drug Administration (FDA) recently approved the American College of Radiology’s (ACR’s) amendment to...
computed tomography brain scan

Image courtesy of Pixabay

News | Clinical Trials | July 19, 2018
The use of computed tomography (CT) scans has increased dramatically over the last two decades. CT scans greatly...
Fujifilm to Host Pediatric Imaging Best Practices Symposium at AHRA 2018
News | Pediatric Imaging | July 18, 2018
Fujifilm Medical Systems U.S.A. Inc. announced that it will offer educational opportunities and exhibit its latest...
Overlay Init